COVID-19 vaccine development pipeline gears up

gracielle

Registered
....Would a vaccine protect everyone?
Not everyone responds the same to immunization. People will be watching the results in older people closely, because they are most at risk from the virus. But history also suggests any vaccine could be less successful in old people because an aged immune system does not respond as well to immunization. We see this every year with the annual flu jab. It may be possible to overcome this by either giving multiple doses or giving it alongside a (called an adjuvant) that gives the immune system a boost.

 

Rich One

Registered
Pfizer CEO Alfred Bourla, sold US$5.6 MM of his Pfizer stock on the day of the press release announcing, 90 % efficacy. when the stock went up 19% ..!

A caveat is the -70 C storage requirement for the Pfizer vaccine. Not available in Argentina
 

gracielle

Registered
Pfizer CEO Alfred Bourla, sold US$5.6 MM of his Pfizer stock on the day of the press release announcing, 90 % efficacy. when the stock went up 19% ..!
There is more to this piece of news....
 

Wade K.

Registered
I have more faith in Russian technology. When Putin uses a Russian poison against an opponent its closer to 99% effective.
True, Russia is known far and wide for the quality of its research and development which has resulted in products that dominate the worldwide markets and are the envy of Europe, the U.S., Japan, South Korea, and China. What could possibly go wrong? :)
 

gracielle

Registered
A caveat is the -70 C storage requirement for the Pfizer vaccine. Not available in Argentina
 

gracielle

Registered
11 November 2020
The Intransigent with Dr. Nelson Castro. Interview: Jorge Asís on the Russian vaccine: «For now, it was a media advertisement by Alberto Fernández»
The journalist and writer Jorge Asís, as he does every Wednesday, spoke with Luis Novaresio on "Animales Sueltos." The same political analyst who was the first to report on the trip to Russia by the Secretary for Access to Health, Carla Vizzotti. The writer affirmed that within the government of Alberto Fernández there is "a spring period" and that can come to an end "if the deal is not closed." The analyst referred to the Russian vaccine and the delay from the Executive to "issue a purchase order."

In this sense, he said that "everything is fine" between the national and Russian governments, but that, until now, "it was only a media announcement." Within this framework, Asís denied that "eleven million doses" will be available for December. The political analyst assured that "at most, only 500,000 vaccines will arrive." "There could be an excessive loquacity on the part of Fernández that does not match reality," he said.

Likewise, Jorge Asís reported that, the province of Buenos Aires, seeks to "rush" ANMAT with the authorization papers for the Russian vaccine. "While moving forward with all the bureaucracy of an import, we wait for a purchase order that does not appear," said the political analyst. “Every day that passes, that possibility of acquiring 25 million will become very difficult. If it continues like this, I bet you that not even three million will arrive by December ", analyzed Asís tonight in "Animales Sueltos".

“From the national government there is no determination to close the deal with the Russians. This happens, because, I think there are enthusiasms without follow through. There is a certain amateurism on the part of the Executive. They (Alberto Fernández and Axel Kicillof) spoke with (President of Russia) Vladimir Putin and could not exploit that dialogue. In other words, talking to Putin is 'more or less' important. However, what is behind, is the fight of laboratories to carry out all the bureaucratic processes of the vaccine, "he said.
 
Top